Page 92 - Cardiac Nursing

0/2
0/2
6/3
6/3
009
1
5:3
009
1
0
q
q
68.
68.
q
0
0
xd
xd
5:3
p
p
8 A
8 A
p
r
r
ta
ta
e 6
Pa
Pa
3
3
Pa
g
e 6
g
g
04
p
p
2-0
2-0
04
LWBK340-c02_
LWB
LWB K34 0-c 02_ pp042-068.qxd 06/30/2009 15:33 Page 68 Aptara a a
02_
0-c
K34
68 PA R T I / Anatomy and Physiology
171. Gurney, A. M. (2002). Multiple sites of oxygen sensing and their con- 182. Krogh, A. (1999). The number and distribution of capillaries in muscles
tributions to hypoxic pulmonary vasoconstriction. Respiratory Physiology with calculations of the oxygen pressure head necessary for supplying the
& Neurobiology, 132, 43–53. tissue. Journal of Physiology, 52, 409–415.
172. Griffiths, M. J., & Evans, T. W. (2005). Inhaled nitric oxide therapy in 183. Tsai, A. G., Johnson, P. C., & Intaglietta, M. (2007). Is the distribution
adults. New England Journal of Medicine, 353, 2683–2695. of tissue pO(2) homogeneous? Antioxidants and Redox Signals, 9,
173. Adhikari, N. K., Burns, K. E., Friedrich, J. O., et al. (2007). Effect of 979–984.
nitric oxide on oxygenation and mortality in acute lung injury: System- 184. Tsai A. G., Johnson P. C., & Intaglietta, M. (2003). Oxygen gradients
4
atic review and meta-analysis. BMJ, 334, 779. in the microcirculation. Physiology in Review, 83, 933–963.
4
174. Kanthapillai, P., Lasserson, T., & Walters, E. (2004). Sildenafil for pul- 185. Tsai, A. G., Friesenecker, B., Cabrales, P., et al. (2006). The vascular wall
monary hypertension. Cochrane Database Systematic Reviews, CD003562. as a regulator of tissue oxygenation. Current Opinion in Nephrology and
175. Liu, C., Liu, K., Ji, Z., et al. (2006). Treatments for pulmonary arterial Hypertension, 15, 67–71.
hypertension. Respiratory Medicine, 100, 765–774. 186. Erusalimsky, J. D., & Moncada, S. (2007). Nitric oxide and mitochon-
176. Price, L. C., & Howard, L. S. (2008). Endothelin receptor antagonists drial signaling: From physiology to pathophysiology. Arteriosclerosis,
7
7
for pulmonary arterial hypertension: rationale and place in therapy. Thrombosis, and Vascular Biology, 27, 2524–2531.
American Journal of Cardiovascular Drugs, 8, 171–185. 187.Fink, M. P. (2002). Bench-to-bedside review: Cytopathic hypoxia.
6
6
177. Paramothayan, N. S., Lasserson, T. J., Wells, A. U., et al. (2005). Prosta- Critical Care, 6, 491–499.
cyclin for pulmonary hypertension in adults. Cochrane Database System- 188. Jensen, F. B. (2004). Red blood cell pH, the Bohr effect, and other
atic Reviews, CD002994. oxygenation-linked phenomena in blood O2 and CO2 transport. Acta
178. Levitzky, M. (2007). Pulmonary physiology. New York: McGraw-Hill. Physiologica Scandinavia, 182, 215–227.
179. Pinsky, M. (2002). Role of cardiorespiratory system in delivering oxy- 189. Shibutani, K., Komatsu, T., Kubal, K., et al. (1983). Critical level of oxy-
gen. In W. Sibbald, K. Messmer, & M. Fink (Eds.), Tissue oxygenation in gen delivery in anesthetized man. Critical Care Medicine, 11, 640–643.
acute medicine (pp. 3–13). Berlin: Springer-Verlag. 190. Ronco J. J., Fenwick J. C., Tweeddale M. G., et al. (1993). Identifica-
180. Leach, R. M., & Treacher, D. F. (2002). The pulmonary physician in tion of the critical oxygen delivery for anaerobic metabolism in critically
critical care: Oxygen delivery and consumption in the critically ill. ill septic and nonseptic humans. Journal of the American Medical Associ-
7
7
Thorax, 57, 170–177. ation, 270, 1724–1730.
181. Wilson, D. F. (2008). Quantifying the role of oxygen pressure in tissue 191. Lieberman, J. A., Weiskopf, R. B., Kelley S. D., et al. (2000). Critical
function. American Journal of Physiology of Heart Circulation Physiology, oxygen delivery in conscious humans is less than 7.3 ml O2 kg( 1)
4
294, H11–H13. min( 1). Anesthesiology, 92, 407–413.
4